The UT Horizon Fund is the strategic venture fund of the University of Texas System.
Our dual mission is to improve commercialization of technologies out of research at UT System institutions (strategic goal) and provide a positive return on investment (financial goal).
Expanding the Horizon
Apollo Endosurgery Announces Acquisition of Obesity Intervention Division from Allergan, Inc.Apollo Endosurgery, Inc., a leading developer of medical devices and endoscopic surgical procedures, today announced that it has entered into a definitive agreement to purchase the obesity intervention division of Allergan, Inc. for up to $110 million. The total includes …Read More